BOROSCI quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.
Borosil Scientific Ltd reported sales of ₹114.96 Cr, operating profit of ₹10.71 Cr (OPM 9.32%) and net profit of ₹5.3 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.
BOROSCI quarterly results (₹ Cr)
Metric
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
101.45
129.48
95.98
106.9
121.3
143.17
106.75
114.96
Expenses
91.44
112.91
91.12
98.87
104.11
111.06
98.3
104.25
Operating Profit
10.01
16.57
4.86
8.03
17.19
32.11
8.45
10.71
OPM
9.87%
12.8%
5.06%
7.51%
14.17%
22.43%
7.92%
9.32%
Other Income
1.86
2.59
-3.69
2.15
0.5
2.06
2.67
2.41
Interest
0.35
0.44
0.38
0.23
0.26
0.26
0.25
0.22
Depreciation
4.58
4.7
4.88
4.81
4.79
4.76
4.89
5.22
Profit before tax
6.94
14.02
-4.09
5.14
12.64
29.15
5.98
7.68
Tax
38.33%
38.52%
3.18%
44.36%
31.25%
6.52%
27.09%
30.86%
Net Profit
4.28
8.62
-4.21
2.84
8.7
27.25
4.35
5.3
EPS in Rs
0.48
0.97
-0.47
0.32
0.98
3.06
0.49
0.6
BOROSCI profit & loss, annual (₹ Cr)
Metric
Mar 2024
Mar 2025
Mar 2026
TTM
Sales
392
434
462
486
Expenses
345
381
400
418
Operating Profit
47
53
63
68
OPM
12%
12%
14%
14%
Other Income
4
8
0
8
Interest
3
2
1
1
Depreciation
16
18
19
20
Profit before tax
32
40
43
55
Tax
26%
34%
19%
-
Net Profit
23
27
35
46
EPS in Rs
2.65
3.01
3.89
5.13
Dividend Payout
0%
0%
0%
-
BOROSCI balance sheet (₹ Cr)
Metric
Mar 2024
Mar 2025
Sep 2025
Mar 2026
Sep 2026
Equity Capital
9
9
9
9
9
Reserves
367
395
396
432
443
Borrowings
18
14
9
9
6
Other Liabilities
95
86
89
90
95
Total Liabilities
488
504
502
540
553
Fixed Assets
192
187
185
189
199
CWIP
1
1
2
9
1
Investments
0
105
108
122
123
Other Assets
295
210
207
220
230
Total Assets
488
504
502
540
553
BOROSCI cash flows (₹ Cr)
Metric
Mar 2024
Mar 2025
Mar 2026
Cash from Operating Activity
30
120
43
Cash from Investing Activity
-2
-115
-37
Cash from Financing Activity
-16
-3
-6
Net Cash Flow
12
1
0
Free Cash Flow
17
106
16
CFO/OP
97%
249%
93%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit